• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-10a 通过调节 Eph 酪氨酸激酶受体 A4 介导的上皮-间充质转化和肝癌细胞黏附参与转移过程。

MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells.

机构信息

Tianjin Life Science Research Center and Basic Medical School, Tianjin Medical University, Tianjin, PR China.

出版信息

Hepatology. 2013 Feb;57(2):667-77. doi: 10.1002/hep.26071. Epub 2013 Jan 8.

DOI:10.1002/hep.26071
PMID:22996586
Abstract

UNLABELLED

MicroRNAs (miRNAs) have been reported to be associated with the development of cancers. However, the function of miRNAs in human hepatocellular carcinoma (HCC) remains largely undefined. Here we found that overexpression of miR-10a promoted the migration and invasion of QGY-7703 and HepG2 cells in vitro but suppressed metastasis in vivo. Cell adhesion assays showed that miR-10a suppressed HCC cell-matrix adhesion, which could explain the results of the in vivo animal experiments. The Eph tyrosine kinase receptor, EphA4, was identified as the direct and functional target gene of miR-10a. Knockdown of EphA4 phenocopied the effect of miR-10a and ectopic expression of EphA4 restored the effect of miR-10a on migration, invasion, and adhesion in HCC cells. We further demonstrated that miR-10a and EphA4 regulated the epithelial-mesenchymal transition process and the β1-integrin pathway to affect cell invasion and adhesion.

CONCLUSION

Our findings highlight the importance of miR-10a in regulating the metastatic properties of HCC by directly targeting EphA4 and may provide new insights into the pathogenesis of HCC.

摘要

未标记

据报道,微小 RNA(miRNAs)与癌症的发展有关。然而,miRNAs 在人肝细胞癌(HCC)中的功能在很大程度上尚未确定。在这里,我们发现 miR-10a 的过表达促进了 QGY-7703 和 HepG2 细胞在体外的迁移和侵袭,但抑制了体内的转移。细胞黏附实验表明,miR-10a 抑制了 HCC 细胞与基质的黏附,这可以解释体内动物实验的结果。Eph 酪氨酸激酶受体 EphA4 被鉴定为 miR-10a 的直接和功能靶基因。EphA4 的敲低模拟了 miR-10a 的作用,而 EphA4 的异位表达恢复了 miR-10a 对 HCC 细胞迁移、侵袭和黏附的作用。我们进一步证明,miR-10a 和 EphA4 通过调节上皮-间充质转化过程和β1-整合素途径来影响细胞侵袭和黏附。

结论

我们的研究结果强调了 miR-10a 通过直接靶向 EphA4 调节 HCC 转移特性的重要性,并可能为 HCC 的发病机制提供新的见解。

相似文献

1
MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells.MicroRNA-10a 通过调节 Eph 酪氨酸激酶受体 A4 介导的上皮-间充质转化和肝癌细胞黏附参与转移过程。
Hepatology. 2013 Feb;57(2):667-77. doi: 10.1002/hep.26071. Epub 2013 Jan 8.
2
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.微小RNA-451:上皮-间质转化抑制剂及肝细胞癌的预后生物标志物
Oncotarget. 2015 Jul 30;6(21):18613-30. doi: 10.18632/oncotarget.4317.
3
Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma.长链非编码RNA TUSC7作为miR-10a的分子海绵并抑制肝细胞癌中的上皮-间质转化。
Tumour Biol. 2016 Aug;37(8):11429-41. doi: 10.1007/s13277-016-4892-6. Epub 2016 Mar 22.
4
MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.微小RNA-379-5p通过靶向肝细胞癌中的FAK/AKT信号传导抑制肿瘤侵袭和转移。
Cancer Lett. 2016 May 28;375(1):73-83. doi: 10.1016/j.canlet.2016.02.043. Epub 2016 Mar 2.
5
miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.miR-300 通过靶向 FAK/PI3K/AKT 信号通路调节肝癌的上皮-间充质转化和侵袭。
Biomed Pharmacother. 2018 Jul;103:1632-1642. doi: 10.1016/j.biopha.2018.03.005. Epub 2018 May 7.
6
Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.微小RNA-129-3p的甲基化相关沉默通过靶向极光激酶A促进肝细胞癌的上皮-间质转化、侵袭和转移。
Oncotarget. 2016 Nov 22;7(47):78009-78028. doi: 10.18632/oncotarget.12870.
7
miR-10a controls glioma migration and invasion through regulating epithelial-mesenchymal transition via EphA8.微小RNA-10a通过EphA8调控上皮-间质转化来控制胶质瘤的迁移和侵袭。
FEBS Lett. 2015 Mar 12;589(6):756-65. doi: 10.1016/j.febslet.2015.02.005. Epub 2015 Feb 12.
8
miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.miR-345通过靶向肝细胞癌中IRF1介导的mTOR/STAT3/AKT信号通路抑制肿瘤转移和上皮-间质转化。
Int J Oncol. 2017 Mar;50(3):975-983. doi: 10.3892/ijo.2017.3852. Epub 2017 Jan 17.
9
Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.长链非编码 RNA CASC2 通过 CASC2/miR-367/FBXW7 轴抑制肝癌细胞的上皮-间充质转化。
Mol Cancer. 2017 Jul 17;16(1):123. doi: 10.1186/s12943-017-0702-z.
10
miRNA-10a-5p inhibits cell metastasis in hepatocellular carcinoma via targeting SKA1.miRNA-10a-5p 通过靶向 SKA1 抑制肝癌细胞转移。
Kaohsiung J Med Sci. 2021 Sep;37(9):784-794. doi: 10.1002/kjm2.12392. Epub 2021 May 17.

引用本文的文献

1
miRNAs in HCC, pathogenesis, and targets.肝癌中的微小RNA、发病机制及靶点。
Hepatology. 2024 Nov 29. doi: 10.1097/HEP.0000000000001177.
2
Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.伴有子宫内膜异位症的卵巢透明细胞癌的转录组分析。
Front Endocrinol (Lausanne). 2023 Aug 9;14:1162786. doi: 10.3389/fendo.2023.1162786. eCollection 2023.
3
Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma.基于 MicroRNA 的治疗策略在肝细胞癌中的新作用。
Mol Biol Rep. 2023 Sep;50(9):7681-7691. doi: 10.1007/s11033-023-08586-z. Epub 2023 Jul 7.
4
Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.微小 RNA 的参与及其在肝细胞癌中的潜在诊断、治疗和预后作用。
J Clin Lab Anal. 2022 Oct;36(10):e24673. doi: 10.1002/jcla.24673. Epub 2022 Aug 29.
5
Activating transcription factor 2 promotes the progression of hepatocellular carcinoma by inducing the activation of the WHSC1-mediated TOP2A/PI3K/AKT axis.激活转录因子 2 通过诱导 WHSC1 介导的 TOP2A/PI3K/AKT 轴的激活促进肝细胞癌的进展。
Kaohsiung J Med Sci. 2022 Jul;38(7):662-674. doi: 10.1002/kjm2.12536. Epub 2022 Apr 8.
6
Serum levels of microRNA-21 and microRNA-10a can predict long-term prognosis in laryngeal cancer patients: a multicenter study.血清微小RNA-21和微小RNA-10a水平可预测喉癌患者的长期预后:一项多中心研究。
Transl Cancer Res. 2020 May;9(5):3680-3690. doi: 10.21037/tcr-20-1758.
7
MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review.微小RNA在肝细胞癌发病机制中的研究进展:综述
Cancers (Basel). 2021 Jan 29;13(3):514. doi: 10.3390/cancers13030514.
8
Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma.高三尖杉酯碱通过调节 EphB4 介导的β-连环蛋白丢失抑制肝癌细胞增殖和迁移。
Cell Death Dis. 2020 Aug 14;11(8):632. doi: 10.1038/s41419-020-02902-2.
9
miR-639 Expression Is Silenced by DNMT3A-Mediated Hypermethylation and Functions as a Tumor Suppressor in Liver Cancer Cells.miR-639 的表达受到 DNMT3A 介导的高甲基化沉默,并在肝癌细胞中作为肿瘤抑制因子发挥作用。
Mol Ther. 2020 Feb 5;28(2):587-598. doi: 10.1016/j.ymthe.2019.11.021. Epub 2019 Nov 28.
10
MicroRNA-10a Impairs Liver Metabolism in Hepatitis C Virus-Related Cirrhosis Through Deregulation of the Circadian Clock Gene Brain and Muscle Aryl Hydrocarbon Receptor Nuclear Translocator-Like 1.微小RNA-10a通过失调昼夜节律钟基因脑和肌肉芳烃受体核转运体样蛋白1损害丙型肝炎病毒相关性肝硬化中的肝脏代谢。
Hepatol Commun. 2019 Sep 26;3(12):1687-1703. doi: 10.1002/hep4.1431. eCollection 2019 Dec.